Biocon Biologics, 6.67% 9oct2029, USD (FIGI RegS BBG01Q3XHGF5, WKN A3L4JD)
国際債券, 保証付き, トレース適格, Secured
国際債券, 保証付き, トレース適格, Secured
|
Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is is a subsidiary of Biocon Limited. Biocon Biologics was incorporated on ...
Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is is a subsidiary of Biocon Limited. Biocon Biologics was incorporated on 8 June, 20176 and is located in Bangalore, India.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
161 443
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡